Kemira Oyj Second Quarter 2025 Earnings: EPS Misses Expectations

Simply Wall St

July 21, 2025

Kemira Oyj (HEL:KEMIRA) Second Quarter 2025 Results

Key Financial Results

Revenue: €693.8m (down 5.4% from 2Q 2024).
Net income: €54.4m (down 12% from 2Q 2024).
Profit margin: 7.8% (down from 8.5% in 2Q 2024). The decrease in margin was driven by lower revenue.
EPS: €0.35 (down from €0.40 in 2Q 2024).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

earnings-and-revenue-growth — HLSE:KEMIRA Earnings and Revenue Growth July 21st 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Kemira Oyj EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.4%.

Looking ahead, revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 3.0% growth forecast for the Chemicals industry in Europe.

Performance of the market in Finland.

The company's share price is broadly unchanged from a week ago.

Valuation

Following the latest earnings results, Kemira Oyj may be undervalued based on 6 different valuation benchmarks we assess. To access our thorough examination of analyst consensus click here and discover the expected future direction of the company.

Valuation is complex, but we're here to simplify it.

Discover if Kemira Oyj might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.